Cristillo, Viviana http://orcid.org/0000-0003-2457-8168
Pilotto, Andrea
Benussi, Alberto
Libri, Ilenia
Giunta, Marcello
Morotti, Andrea
Gipponi, Stefano
Locatelli, Martina
Piccinelli, Stefano Cotti
Mazzoleni, Valentina
di Cola, Francesca Schiano
Masciocchi, Stefano
Pezzini, Debora
Scalvini, Andrea
Premi, Enrico
Cottini, Elisabetta
Gamba, Massimo
Magoni, Mauro
Fontanella, Marco Maria
Padovani, Alessandro
Article History
Received: 3 November 2021
Accepted: 6 February 2022
First Online: 17 February 2022
Declarations
:
: V. Cristillo, A. Benussi, I. Libri, M. Giunta, A. Morotti, S. Gipponi, M. Locatelli, S. Cotti Piccinelli, V. Mazzoleni, F. Schiano di Cola, S. Masciocchi, D. Pezzini, A. Scalvini, E. Premi, E. Cottini, M. Gamba, M. Magoni, M. M. Fontanella report no disclosures relevant to the manuscript. Andrea Pilotto received speaker honoraria and travel grants from AbbVie Pharmaceuticals BioMarin Pharmaceutical, Chiesi Pharmaceuticals, Nutricia Pharmaceuticals, UCB Pharma, and Zambon Pharmaceuticals. Alessandro Padovani is consultant and served on the scientific advisory board of GE Healthcare, Eli-Lilly, and Actelion Ltd. Pharmaceuticals; and received speaker honoraria from Nutricia, PIAM, Lansgstone Technology, GE Healthcare, Lilly, UCB Pharma, and Chiesi Pharmaceuticals.
: The Neuro-COVID Next study was approved by the local ethics committee of ASST Spedali Civili di Brescia Hospital (NP 4067, approved 08.05.2020).